Candel Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CADL and other ETFs, options, and stocks.About CADL
Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110.
CEOPaul-Peter Tak
CEOPaul-Peter Tak
Employees38
Employees38
HeadquartersNeedham, Massachusetts
HeadquartersNeedham, Massachusetts
Founded2002
Founded2002
Employees38
Employees38
CADL Key Statistics
Market cap317.31M
Market cap317.31M
Price-Earnings ratio-11.35
Price-Earnings ratio-11.35
Dividend yield—
Dividend yield—
Average volume1.27M
Average volume1.27M
High today$6.58
High today$6.58
Low today$5.74
Low today$5.74
Open price$6.42
Open price$6.42
Volume1.26M
Volume1.26M
52 Week high$13.68
52 Week high$13.68
52 Week low$4.25
52 Week low$4.25
Stock Snapshot
The current Candel Therapeutics(CADL) stock price is $5.76, with a market capitalization of 317.31M. The stock trades at a price-to-earnings (P/E) ratio of -11.35.
On 2025-12-15, Candel Therapeutics(CADL) stock moved within a range of $5.74 to $6.58. With shares now at $5.76, the stock is trading +0.4% above its intraday low and -12.5% below the session's peak.
Trading volume for Candel Therapeutics(CADL) stock has reached 1.26M, versus its average volume of 1.27M.
Over the past 52 weeks, Candel Therapeutics(CADL) stock has traded between a high of $13.68 and a low of $4.25.
Over the past 52 weeks, Candel Therapeutics(CADL) stock has traded between a high of $13.68 and a low of $4.25.
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own CADL. This list is generated using Robinhood data, and it’s not a recommendation.